CA Dermatology & Clinical Research Institute in Encinitas conducts Phase I through Phase IV dermatology clinical trials from its Saxony Place facility, established in 2013 under board-certified research dermatologist Dr. Stacy R. Smith. Clinical trial eligibility screening for participants with complex medical histories coordinates pre-enrollment medical evaluation with primary care providers such as Kind Health Group for baseline laboratory and medication review. The research portfolio spans investigational drugs, biologics, devices, and topical formulations across therapeutic areas including plaque psoriasis, acne vulgaris, atopic dermatitis, verrucae, hyperhidrosis, alopecia areata, and vitiligo. Principal-investigator experience spanning the early 2000s through the present has contributed to FDA approval pathways for multiple dermatologic treatments now in standard clinical use across the United States. Post-procedural wound monitoring for device-based and injectable clinical trials follows structured healing assessment timelines developed in coordination with rehabilitation specialists including Gaspar Doctors of Physical Therapy for tissue-remodeling evaluation. The institute's most advanced protocols include randomized, double-blind, placebo-controlled multicenter studies evaluating novel biologic mechanisms of action targeting interleukin and Janus kinase pathways in moderate-to-severe inflammatory dermatoses.